Tysabri news is good for ISEQ
The ISEQ index climbed 121.78 points to 7894.62 this morning.
Elan soared €2.40 (21.2%) to €13.70 following news that multiple sclerosis drug Tysabri is expected to be approved to go back on sale shortly. It was the morning’s busiest share.
The Business Hub
Newsletter
News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.





